Skip to Main Content

FTC

Read STAT’s coverage of the Federal Trade Commission (FTC), the nation’s consumer protection agency. Learn about the FTC’s latest investigations, enforcement actions, and consumer alerts as they relate to health, science and medicine. Articles on this page include requests for price hike investigations, antitrust issues related to mergers and industry consolidation, and controversies over generic drugs.

Latest

Insurance Bob Herman

STAT Plus: Explaining Change Healthcare and the gravity of its cyberattack

D.C. Diagnosis Rachel Cohrs

Long Covid research gets a big-time funding boost

Pharmalot Ed Silverman and John Wilkerson

STAT Plus: FTC to probe the role of middlemen in worsening drug shortage crisis

Business Bob Herman

STAT Plus: FTC doubles down in Welsh Carson anesthesia case to limit private equity’s physician buyouts

Hospitals Tara Bannow

STAT Plus: FTC sues to block a proposed hospital deal in North Carolina

Pharmalot Ed Silverman

STAT Plus: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’

First Opinion Sneha Dave, Sydney Reed, and Steven Woloshin

The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs

Politics Brittany Trang

STAT Plus: HHS names inaugural chief competition officer

All Coverage

Insurance Bob Herman

STAT Plus: Hot antitrust environment hangs over called-off merger between Cigna and Humana

Pharmalot Ed Silverman

STAT Plus: Most drugmakers have so far ignored looming FTC deadline to withdraw or amend wayward patents

advertisement

Health Care Inc. Bob Herman

Kaiser Permanente workers announce an official strike date

Hospitals Tara Bannow

STAT Plus: Patients, doctors press FTC to beef up hospital merger scrutiny

First Opinion Jacqueline Seitz

STAT Plus: Where are HHS and the FTC on online privacy for people with substance use disorder?

Pharmalot Ed Silverman

STAT Plus: FTC warns drugmakers they can face legal action over improper patent listings

Pharmalot Ed Silverman

STAT Plus: U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs

Health tech Katie Palmer

STAT Plus: ‘No data more personal’: Patients, digital health players weigh in on the FTC’s data privacy plan

Pharmalot Ed Silverman

STAT Plus: FTC plans to reverse years of policy statements supporting pharmacy benefit managers

Hospitals Tara Bannow and Bob Herman

STAT Plus: DOJ, FTC primed for more aggressive scrutiny of health care mergers

Pharmalot Ed Silverman

STAT Plus: FTC move to block the Amgen-Horizon deal highlights concerns over negotiations with insurers

Hospitals Bob Herman

STAT Plus: HCA, Louisiana hospital system sue FTC over review of hospital deal

Hospitals John Wilkerson

STAT Plus: Government antitrust officials consider letting physician-owned hospitals expand

Business Jonathan Wosen

STAT Plus: Illumina wins case against FTC in bid to hold onto early cancer detection company Grail

Hospitals Tara Bannow

STAT Plus: Hospital mergers that dodge antitrust scrutiny lead to dramatically higher prices, study finds

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Sarepta halts a Duchenne clinical trial over safety; Why the CVS Health whistleblower lawsuit comes at a pivotal moment

Hospitals Bob Herman

STAT Plus: New Jersey hospitals scrap merger after FTC challenge

D.C. Diagnosis Lev Facher

The Senate health committee finally marks up its user fee bill

Exclusive Rachel Cohrs

STAT Plus: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

Hospitals Tara Bannow

STAT Plus: The FTC says it’s getting tougher on hospital consolidation. Antitrust experts aren’t buying it

Pharmalot Ed Silverman

STAT Plus: Lawmakers ask FTC to scrutinize pharma mergers over antitrust concerns